icon-folder.gif   Conference Reports for NATAP  
 
  AASLD/EASL Special Conference
on Hepatitis C
New York City, New York
September 12 - 13
Back grey_arrow_rt.gif
 
 
 
Open Label Study to Evaluate Safety, Tolerability, and Efficacy of Telaprevir (TVR) in Combination with Sofosbuvir (SOF) in Treatment-na´ve Patients with Genotype 1 Hepatitis C Virus Infection
 
 
  Reported by Jules Levin
NY AASLD/EASL HCV Special Symposium Sept 2014
 
Morelli G1, Firpi R1, Horne P1, Peter J1, Akushevich L2, Vainorius M2, George S3, Kieffer T3, Garg V3, Fried MW2, Nelson DR1
University of Florida1, University of North Carolina2, and Vertex Pharmaceuticals Inc3.

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif